investordatabase.org

DNA Capital

dnacapital.com Direct investor

DNA Capital is a healthcare-focused investment firm that partners with companies across all stages, from early to late stage, providing capital and operational support. It has a portfolio of healthcare companies and a team of specialists.

DNA Capital is a private equity firm headquartered in Brazil. It invests directly in companies, from Series A to growth, in healthcare and healthtech. 28 portfolio companies, as it reports.

“We partner with exceptional founders and management teams across all stages to build leading healthcare businesses.”

— DNA Capital, own website
Layer
Direct investor
Type
Private equity
Stage
Series A – Growth
Headquarters
Brazil
Invests in
global
Sectors
healthcare, healthtech
Portfolio
28 companies

Team, as DNA Capital publishes it

  • Camila Guimarães Team
  • Julia Prado Team
  • Mario Sergio Ribeiro Team
  • Thayan Hartmann Team
  • Daniel Studart Team
  • Lucas Cortez Team
  • Partha Mishra Team
  • Henrique Bandeira Team
  • Luiz Felipe Costa Team
  • Pedro Bueno Team
  • José Eduardo Guinle Team
  • Luiz Noronha Team

Names and roles exactly as listed on dnacapital.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page DNA Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 7301 · added 2026-09-05 · link last verified 2026-10-21 · confidence medium

Similar investors

Listed under